Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study.

Medicine

Prensa/medios de comunicación: Research

Períodosep. 11 2023 → sep. 12 2023

Cobertura de los medios

3

Cobertura de los medios

  • Nombre-Sona s THT Cancer Therapy to be assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study
    Nombre/canal del medio de comunicaciónM2 PressWIRE
    País/TerritorioUnited States
    Fecha9/12/23
    PersonasCarman Anthony Giacomantonio
  • Nombre-Sona s THT Cancer Therapy to be assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study
    Nombre/canal del medio de comunicaciónENP Newswire
    País/TerritorioUnited Kingdom
    Fecha9/12/23
    PersonasCarman Anthony Giacomantonio
  • NombreSona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study.
    Nombre/canal del medio de comunicaciónFinancial News Releases
    País/TerritorioCanada
    Fecha9/11/23
    PersonasCarman Anthony Giacomantonio
Ver todos 3
Ver menos